Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.68
-0.69 (-8.24%)
At close: Aug 28, 2026, 4:00 PM EDT
7.79
+0.11 (1.40%)
After-hours: Aug 28, 2026, 7:46 PM EDT
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nucleic Acid Production | 142.10M | 138.51M | 119.79M | 127.09M | 155.58M | 182.98M | 200.24M | 217.17M | |||||||||||||||
| Nucleic Acid Production Growth | -8.67% | -24.30% | -40.18% | -41.48% | -27.49% | -12.59% | -10.91% | -38.87% | |||||||||||||||
| Biologics Safety Testing | 66.68M | 66.22M | 65.96M | 65.35M | 64.25M | 62.86M | 62.92M | 63.58M | |||||||||||||||
| Biologics Safety Testing Growth | 3.78% | 5.35% | 4.83% | 2.79% | 0.34% | -2.95% | -1.96% | -1.10% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biologics Safety Testing | 45.64M | 45.13M | 44.24M | 43.61M | 44.00M | 42.59M | 43.84M | 45.90M | |||||||||||||||
| Biologics Safety Testing Growth | 3.73% | 5.97% | 0.91% | -4.98% | -4.80% | -9.56% | -6.54% | -1.33% | |||||||||||||||
| Nucleic Acid Production | 17.31M | 3.01M | -23.15M | -20.12M | 3.25M | 31.83M | 50.81M | 70.85M | |||||||||||||||
| Nucleic Acid Production Growth | 431.93% | -90.54% | - | - | -95.48% | -50.94% | -38.53% | -63.50% |
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 119.44M | 118.80M | 112.38M | 111.65M | 121.31M | 122.99M | 127.09M | 132.08M | |||||||||||||||
| North America Growth | -1.54% | -3.41% | -11.58% | -15.47% | -8.03% | -8.16% | -9.90% | -24.52% | |||||||||||||||
| EMEA | 58.60M | 56.54M | 41.47M | 30.92M | 30.42M | 39.57M | 42.06M | 50.53M | |||||||||||||||
| EMEA Growth | 92.66% | 42.90% | -1.38% | -38.81% | -40.00% | -21.33% | -15.76% | -61.36% | |||||||||||||||
| APAC | 29.40M | 28.24M | 30.92M | 48.96M | 63.54M | 78.80M | 89.38M | 93.60M | |||||||||||||||
| APAC Growth | -53.73% | -64.17% | -65.40% | -47.69% | -33.33% | -11.67% | -8.27% | -17.24% | |||||||||||||||
| Latin and Central America | 1.34M | 1.15M | 971.00K | 757.00K | 586.00K | 501.00K | 662.00K | 706.00K | |||||||||||||||
| Latin and Central America Growth | 127.82% | 130.34% | 46.68% | 7.22% | -14.58% | -26.43% | 25.62% | 8.78% |